Stock-based compensation is one of the most complex areas of accounting for startups and high-growth companies. Unlike a cash salary, equity awards require careful tracking across grant dates, vesting periods, and exercise dates — each step generating its own journal entries. This guide walks through every journal entry you will need, with debit and credit examples using real numbers.
Why Stock-Based Compensation Accounting Matters
For a startup, stock options and RSUs are a form of non-cash compensation that must be recognized as an expense on the income statement. The amount is not arbitrary — it is calculated using fair value methods prescribed by ASC 718 (US GAAP) or IFRS 2 (for IFRS reporters). Undervaluing your equity compensation creates restatement risk; overvaluing it inflates your expenses and destroys founder and employee trust in their awards.
The fair value of a stock option is determined at the grant date using an option-pricing model (typically Black-Scholes-Merton or a lattice model). That fair value is then recognized as compensation expense over the vesting period, not all at once at grant.
Key Definitions Before You Start
- Grant date — The date the company awards equity to an employee. This is when the terms become mutualy understood.
- Vesting period — The time an employee must remain employed before options/shares are fully earned. Common structures are 4-year with a 1-year cliff.
- Cliff vesting — No shares vest until the cliff date; after the cliff, shares vest monthly or quarterly.
- Exercise price — The price the employee pays to purchase shares (also called the strike price).
- Fair value per option — The computed market value of one option at the grant date.
- Forfeiture rate — Estimated percentage of awards that will be forfeited when employees leave before vesting.
1. Stock Options: The Compensation Expense Journal Entry
When a company grants stock options to an employee, it recognizes compensation expense over the vesting period. The cumulative compensation expense is recorded in a Contra-equity account called Stock Options Outstanding (or "Stock-Based Compensation Reserve"). When options are exercised, this reserve is reclassified into the appropriate equity accounts.
Grant Date — No Entry Required (With a Caveat)
At the grant date, if the options have no vesting conditions other than continued employment (a "service condition"), the company estimates the total compensation cost and prepares a memorandum entry. No actual journal entry hits the income statement at this point.
Memorandum entry at grant date:
Dr. Unrecognized Compensation Cost (memo only) — $X
Cr. Stock Options Outstanding (memo only) — $X
The real accounting begins with the first vesting period expense accrual.
Vesting Period — Monthly or Quarterly Expense Recognition
Suppose a company grants 10,000 stock options to an employee on January 1, 2026. Each option has a fair value of $2.50 (computed using Black-Scholes-Merton). The options vest ratably over 4 years (48 months), with no cliff. The total compensation cost is $25,000 ($2.50 × 10,000 shares).
At each month-end during the vesting period, the company recognizes:
Month-end journal entry (months 1–48):
Dr. Compensation Expense — Stock Options — $520.83
Cr. Stock Options Outstanding — $520.83
Calculation: $25,000 ÷ 48 months = $520.83 per month.
If there is a 1-year cliff (25% of shares vest all at once after 12 months, then monthly thereafter), the monthly entries look different:
- Months 1–12: $25,000 × 25% = $6,250 recognized in year 1 ($520.83/month × 12 months)
- Months 13–48: Remaining $18,750 recognized over 36 months ($520.83/month)
Exercise Date — Employee Exercises Options
When the employee exercises options, they pay the exercise price and receive shares. The key is that the exercise price is often less than the fair value of the shares at exercise — that difference is the employee's "bargain element" or intrinsic value gain.
Using the same example: The employee exercises all 10,000 options when the fair value of the shares is $8.00 per share. The exercise price is $3.00 per share.
Exercise date journal entry:
Dr. Cash — $30,000 (10,000 × $3.00 exercise price)
Dr. Stock Options Outstanding — $25,000 (the full previously-recognized compensation reserve)
Cr. Common Shares — $10,000 (10,000 × $1.00 par value, if applicable)
Cr. Additional Paid-In Capital (APIC) — $45,000 (plug: cash + options outstanding minus par)
Alternatively, if there is no par value or a very small par:
Dr. Cash — $30,000
Dr. Stock Options Outstanding — $25,000
Cr. Common Shares — $55,000
The Stock Options Outstanding account is cleared when options are exercised or expire. The reserve for unexercised expired or forfeited options is also reclassified to APIC.
Forfeiture of Unvested Options
If an employee leaves before options are fully vested, unvested options are forfeited. Any previously recognized compensation Expense for those unvested options must be reversed.
Suppose the employee from the example above leaves after 24 months (50% vested). $12,500 of compensation expense was already recognized. The remaining $12,500 in unrecognized cost is written off:
Dr. Stock Options Outstanding — $12,500 (reversing the reserve for unvested/forfeited options)
Cr. Compensation Expense — Stock Options — $12,500 (income effect)
In practice, companies use an estimated forfeiture rate (e.g., 20%) to adjust the monthly expense recognition upward or downward throughout the vesting period.
2. Restricted Stock Units (RSUs): No-Cost, Full-Value Awards
RSUs differ from stock options in a fundamental way: RSUs have no exercise price. The employee receives shares at vesting for free (or pays only nominal taxes). Because there is no cost to exercise, RSUs have a higher fair value at grant than equivalent stock options.
Grant Date
Like options, grant date is a memorandum entry. The company records the number of RSUs awarded and the fair value per share at grant date.
Suppose a company grants 5,000 RSUs to an executive on January 1, 2026, when the fair value is $10.00 per share. Total compensation cost: $50,000. Vesting is 4 years ratably.
Vesting Period — RSU Compensation Expense
Month-end journal entry (months 1–48):
Dr. Compensation Expense — RSUs — $1,041.67
Cr. Stock-Based Compensation Liability (or Contra-equity) — $1,041.67
Calculation: $50,000 ÷ 48 months = $1,041.67 per month.
Note: For RSUs, some companies use a liability method because RSUs are settled in cash or shares at vesting. Under IFRS, RSUs settled in shares create a equity-settled arrangement recorded in Stock-Based Compensation Reserve. Under US GAAP (ASC 718), if the company has a present selement obligation (e.g., net settlement features), the RSU may be classified as a liability and remeasured at fair value each period.
R SU Vesting and Settlement
When RSUs vest, the company issues shares to the employee. The journal entry depends on whether RSUs are settled in shares or cash.
Settlement in shares:
Dr. Stock-Based Compensation Reserve (RSU) — $50,000
Cr. Common Shares — $50,000
Settlement in cash (if classified as liability):
Dr. Stock-Based Compensation Liability — $50,000
Cr. Cash — $50,000
In practice, most tech company RSUs are settled in shares (equity-settled) and the company withholds a portion of shares to cover the employee's tax withholding obligation at vesting.
Tax Withholding at RSU Vesting
When RSUs vest and the employee has a tax obligation, the company often withholds shares. The journal entry for share withholding:
Dr. Stock-Based Compensation Reserve — $X (fair value of withheld shares)
Cr. Cash / Payroll Tax Payable — $X (taxes remitted on behalf of employee)
For example, 5,000 RSUs vest when the fair value is $12.00/share. The company withholds 40% ($24,000) to cover the employee's income tax obligation and remits directly to the tax authority. The employee receives net 3,000 shares:
Dr. Stock-Based Compensation Reserve — $60,000 (5,000 × $12)
Cr. Cash / Payroll Tax Payable — $24,000
Cr. Common Shares — $36,000 (3,000 net shares issued)
3. Stock Appreciation Rights (SARs)
SARs give employees the right to receive a cash payment equal to the appreciation in the company's stock price between grant and exercise. Because they are settled in cash, SARs are always classified as a liability under both ASC 718 and IFRS 2, and must be remeasured to fair value at every reporting date.
Liability Recognition at Each Reporting Date
Suppose a company grants 2,000 SARs on January 1, 2026, with a base price of $5.00/share. At each reporting date (quarterly), the company remeasures the fair value of the SARs liability. Assume the stock price is $7.00 at quarter-end and the fair value per SAR (using a Black-Scholes remeasurement) is $2.20.
Quarter-end remeasurement journal entry:
Dr. Compensation Expense — SARs — $4,400 (2,000 × $2.20 change in fair value)
Cr. Stock Appreciation Rights Liability — $4,400
When the employee exercises SARs (stock price = $8.00, base = $5.00, appreciation = $3.00 per SAR):
Dr. Stock Appreciation Rights Liability — $6,000 (2,000 × $3.00 appreciation)
Cr. Cash — $6,000
4. Key_estimates and Judgments That Drive Your Entries
Three inputs have the largest impact on compensation expense and therefore your journal entries:
1. Fair Value of the Underlying Stock
For private companies, this is the hardest input. Companies typically commission an independent 409A valuation to establish the fair market value of common stock at each grant date. As the company raises funding rounds and the preferred share price changes, the 409A value updates — which may trigger a new calculation of the option fair value for grants made in that period.
2. Volatility
Higher expected volatility in the company's stock price leads to a higher Black-Scholes fair value for options. Startups with high growth potential and no trading history may use "volatility surface" estimates or comparable company volatility. Underestimating volatility undervalues options and understates compensation expense — a common audit finding.
3. Forfeiture Rate
Companies must estimate the percentage of employees who will leave before their awards vest. Most startups use a simple 0–5% annual forfeiture rate for early-stage employees and 0% for founders/executives, then true up each period as actual forfeitures occur. Failing to update forfeiture estimates results in material misstatement of compensation expense over time.
5. Full Worked Example: From Grant to Exercise
Let's walk through a complete lifecycle for a real-world scenario at a Series B startup:
Facts:
- Employee: Senior Engineer
- Award: 20,000 stock options (NSO)
- Grant date: July 1, 2026
- Exercise price: $2.00/share (409A at grant = $4.00/share)
- Fair value per option at grant (Black-Scholes): $1.80
- Vesting: 4 years, 1-year cliff (25% at month 12, then monthly)
- Employee exercises all vested options on June 30, 2029 (3 years later)
- Fair value at exercise date: $12.00/share
- Forfeiture assumption: 0% (employee is a key engineer)
Step 1: Grant date memorandum entry
Dr. Unrecognized Compensation Cost — $36,000 (memo)
Cr. Stock Options Outstanding — $36,000 (memo)
Step 2: Monthly expense — Year 1 (cliff vest)
- Total compensation: 20,000 × $1.80 = $36,000
- Year 1 expense: $36,000 × 25% (cliff) = $9,000 ($750/month × 12 months)
- Year 2–4 expense: $27,000 over 36 months = $750/month
Month-end entries (all months, years 1–4):
Dr. Compensation Expense — Stock Options — $750
Cr. Stock Options Outstanding — $750
Step 3: Cliff vesting at month 12 (June 30, 2027)
5,000 options cliff vest. No additional entry — the monthly accrual already captured the $9,000. Verify the Stock Options Outstanding account shows $9,000 for the vested tranche.
Step 4: Exercise (June 30, 2029)
Assume all 20,000 options are vested (monthly vesting after cliff has run for 24 more months). Cash received by company: 20,000 × $2.00 = $40,000. Intrinsic value to employee: 20,000 × ($12.00 − $2.00) = $200,000.
Dr. Cash — $40,000
Dr. Stock Options Outstanding — $36,000 (fully vested reserve)
Cr. Common Shares — $76,000
After exercise, Stock Options Outstanding is zero. The employee owns 20,000 shares.
Summary: Stock-Based Compensation Journal Entry Cheat Sheet
| Event | Debit | Credit |
|---|---|---|
| Grant date (memo) | Unrecognized Compensation Cost (memo) | Stock Options Outstanding (memo) |
| Vesting period expense (monthly) | Compensation Expense — Stock Options | Stock Options Outstanding |
| Exercise of options | Cash (exercise price) + Stock Options Outstanding | Common Shares (or APIC) |
| Forfeiture of unvested options | Stock Options Outstanding (reverse) | Compensation Expense (income) |
| RSU vesting (equity-settled) | Stock-Based Compensation Reserve | Common Shares |
| RSU vesting (cash-settled) | Stock-Based Compensation Liability | Cash |
| SAR remeasurement (quarterly) | Compensation Expense — SARs | Stock Appreciation Rights Liability |
| SAR exercise | Stock Appreciation Rights Liability | Cash |
Related Articles
- Tax Treatment of Share-Based Compensation in Canada — Learn the tax rules for stock options, RSUs, and PSU deferral elections for Canadian employees and employers.
- Accounting for Share-Based Compensation (IFRS 2) — The IFRS framework for equity-settled awards, including modification accounting and market-based conditions.
- Dilution in Funding Rounds — How equity raises affect founder and investor ownership across seed, Series A, B, and C rounds.
- Convertible Bonds: Accounting for Debt with Equity Conversion Features — Related accounting for hybrid instruments with equity conversion features.
- Journal Entries for the Issuance of Common Shares — The flip side of equity compensation: how to record share issuances and par value accounting.
